Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Retinal Vascular Manifestations in Patients With Common Internal Diseases on Optical Coherence Tomography Angiography

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified. This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up. This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients with hypertension - Or patients with diabetes - Or patients with dyslipidemia - Agree to participate in this study Who Should NOT Join This Trial: - Patients with malignant tumors - Patients with autoimmune conditions (where your immune system attacks your own body)s - Patients with weakened immune system disease - Disagree to participate in this study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients with hypertension * Or patients with diabetes * Or patients with dyslipidemia * Agree to participate in this study Exclusion Criteria: * Patients with malignant tumors * Patients with autoimmune diseases * Patients with immunodeficiency disease * Disagree to participate in this study

Treatments Being Tested

OTHER

No intervention

No intervention

Locations (1)

Beijing Tongren Hospital
Beijing, Beijing Municipality, China